Bei Akademie registrieren
GSK, GB00BN7SWP63

GSK stock pre-market: drugmaker at EUR 22.18 before Xetra open

Published on 10/22/2026 at 08:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
GSK develops medicines and vaccines for human health markets. At Lang & Schwarz the stock trades pre-market at EUR 22.18 on October 22, 2026.

Business model and trading date

  • GSK develops vaccines and medicines for human health markets.
  • The pre-market indication is dated October 22, 2026.
  • GSK stock trades pre-market at EUR 22.18 at 8:17 a.m. CEST at Lang & Schwarz on October 22, 2026.
Moderne Pharma-Produktionsanlage mit Glasfassade und Laboren bei Dämmerlicht
GSK plc (ISIN GB0009252882) betreibt moderne Pharmaanlagen mit Laboren und Produktionshallen in der Abenddämmerung, Illustration mit AI erstellt.

GSK develops vaccines and medicines for human health markets, according to the company’s investor-relations page. The stock is at EUR 22.18 at Lang & Schwarz on October 22, 2026, at 8:17 a.m. CEST.

Pre-market indication

The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of GSK stock.

Business and market context

GSK’s investor-relations materials describe a business focused on developing medicines and vaccines for human health. Market context: Market report FTSE 100.

More news and analysis on GSK stock

Disclaimer...
en | GB00BN7SWP63 | GSK | boerse | 70390702 | bgmi